Zions Bancorporation, National Association’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
28,749
-23,210
-45% -$307K 0.03% 277
2026
Q1
$716K Sell
51,959
-33,027
-39% -$498K 0.05% 216
2025
Q4
$1.53M Buy
84,986
+22,351
+36% +$401K 0.07% 184
2025
Q3
$1.16M Buy
+62,635
New +$984K 0.06% 212

Other funds holding CLBT

Zions Bancorporation, National Association's CLBT Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Cellebrite (CLBT) stake by 45% in Q2 2026, selling an estimated $307K and leaving 28,749 shares worth $420K. The position accounts for 0.03% of the portfolio, ranked #277.

Zions Bancorporation, National Association first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.53M in Q4 2025. 35 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Zions Bancorporation, National Association held 28,749 shares of Cellebrite worth $420K as of Q2 2026.
  • Zions Bancorporation, National Association sold 23,210 Cellebrite shares in Q2 2026, an estimated $307K.
  • Cellebrite made up 0.03% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #277 holding.
  • Zions Bancorporation, National Association first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Zions Bancorporation, National Association's Cellebrite position peaked at $1.53M in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.